TCT-339 Impact of Tricuspid Regurgitation on Thermodilution for Measurement of Cardiac Index

Sternberg, Michael E.; Nicolazzi, Joseph; Patel, Murti; Saado, Jonathan; Kwiatkowski, Sara; Kim, Royce; Bhardwaj, Hem; Gertz, Zachary M.

doi:10.1016/j.jacc.2021.09.1192

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The role of the thermodilution method is still debated since it may underestimate cardiac output when TR is severe. 78,90,91 Low (<1.7 ml/min/m 2 ) and high (>2.6 ml/min/m 2 ) cardiac output values were associated with a lower survival as compared to intermediate cardiac output status among patients undergoing TTVI. 92 Hyperdynamic circulation due to hepatic damage may explain the negative role of a high cardiac output as a marker of advanced disease.…”

Section: Right Heart Catheterizationmentioning

confidence: 95%

Epidemiology, pathophysiology, diagnosis and management of chronic right‐sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

Adamo,

Chioncel,

Pagnesi

et al. 2024

European J of Heart Fail

View full text Add to dashboard Cite

Right‐sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. While medical therapy for right‐sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from tricuspid valve interventions are yet unknown, as is the ideal time for these treatments given the paucity of clinical evidence. In this context, it is crucial to elucidate etiology and pathophysiological mechanisms leading to right‐sided heart failure and tricuspid regurgitation in order to recognize when tricuspid regurgitation is a mere bystander and when it can cause or contribute to heart failure progression. Notably, early identification of right heart failure and tricuspid regurgitation may be crucial and optimal management requires knowledge about the different mechanisms and causes, clinical course and presentation, as well as possible treatment options.The aim of this clinical consensus statement is to summarize current knowledge about epidemiology, pathophysiology and treatment of tricuspid regurgitation in right‐sided heart failure providing practical suggestions for patient identification and management.This article is protected by copyright. All rights reserved.

show abstract